| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 83161 |
cas:2055024-54-7 Boc-PEG4-Val-Cit-PAB-OH |
164 |
zyl |
2024-12-19 |
| 83162 |
Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB-PNP（CAS: 2055042-82-3） |
151 |
WYQ |
2024-12-19 |
| 83163 |
Mal-amido-PEG8-val-gly-PAB-OH（CAS: 2353409-52-4） |
156 |
WYQ |
2024-12-19 |
| 83164 |
cas:160854-54-6，4-succinimidyl-oxycarbonyl-α-(2-pyridyldithio)toluene，ADC定制 |
143 |
wyh |
2024-12-19 |
| 83165 |
cas:2504147-59-3 MC (C5)-Val-Cit |
174 |
zyl |
2024-12-19 |
| 83166 |
Boc-PEG4-Val-Ala-PAB，可降解的ADC连接体 |
179 |
WYQ |
2024-12-19 |
| 83167 |
cas:2058075-34-4，DGN549-C ， ADC试剂 |
242 |
kx |
2024-12-19 |
| 83168 |
CAS: 1639939-40-4，Mal-Val-Ala-PAB-PNP，马来酰亚胺-VAL-ALA-PAB-PNP |
174 |
WYQ |
2024-12-19 |
| 83169 |
Fmoc-VC-PAB-Duocarmycin SA， ADC试剂 |
135 |
kx |
2024-12-19 |
| 83170 |
Mal-PEG4-Val-Ala-PAB，可降解的ADC（抗体偶联药物）连接子 |
232 |
WYQ |
2024-12-19 |
| 83171 |
Mal-PEG1-Val-Cit-OH的介绍 |
191 |
zyl |
2024-12-19 |
| 83172 |
MC-vc-PAB-Monomethyl dolastatin10， ADC试剂 |
129 |
kx |
2024-12-19 |
| 83173 |
CAS: 1870916-87-2，Mal-Val-Ala-PAB，马来酰亚胺-缬氨酸-丙氨酸-对氨基苯甲酸 |
160 |
WYQ |
2024-12-19 |
| 83174 |
cas:2395887-69-9 Mal-PEG2-Val-Cit-PAB-PNP |
133 |
zyl |
2024-12-19 |
| 83175 |
SuO-Val-Cit-PAB-MMAE， ADC试剂 |
129 |
kx |
2024-12-19 |
| 83176 |
Mal-PEG4-Val-Ala-PAB-PNP的介绍 |
135 |
zyl |
2024-12-19 |
| 83177 |
CAS: 2348405-93-4，DBCO-PEG4-Val-Ala-PAB-PNP |
121 |
WYQ |
2024-12-19 |
| 83178 |
CAS: 2348405-92-3，DBCO-PEG4-Val-Ala-PAB |
140 |
WYQ |
2024-12-19 |
| 83179 |
cas:2112738-13-1 Mal-amido-PEG2-Val-Cit-PAB-PNP |
143 |
zyl |
2024-12-19 |
| 83180 |
Azido-PEG4-Val-Ala-PAB，分子式：C29H48N8O9 |
132 |
WYQ |
2024-12-19 |
| 83181 |
cas:2055896-86-9，MC-Val-Cit-PAB-tubulysin5a ， ADC试剂 |
136 |
kx |
2024-12-19 |
| 83182 |
Azido-PEG8-Val-Cit-PAB-PNP |
127 |
zyl |
2024-12-19 |
| 83183 |
cas:2055896-83-6，MC-Val-Cit-PAB-carfilzomib ， ADC试剂 |
144 |
kx |
2024-12-19 |
| 83184 |
MAL-di-EG-Val-Cit-PAB-MMAF， ADC试剂 |
121 |
kx |
2024-12-19 |
| 83185 |
cas:2353409-45-5 endo BCN-PEG3-VC-PFP Ester |
153 |
zyl |
2024-12-19 |
| 83186 |
Hydrazone-doxorubicin， ADC试剂 |
257 |
kx |
2024-12-19 |
| 83187 |
DBCO-C4-Val-Cit-PABC-PNP |
143 |
zyl |
2024-12-19 |
| 83188 |
cas:644981-35-1 Val-Cit-PAB-MMAE |
138 |
zyl |
2024-12-19 |
| 83189 |
cas:170908-81-3，DOTA-NHS ester ，1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 1-(2,5-二氧代-1-吡咯烷基)酯 |
117 |
kx |
2024-12-19 |
| 83190 |
endo-BCN-PEG4-Val-Cit-PAB-MMAE的介绍 |
132 |
zyl |
2024-12-19 |
| 83191 |
cas:2259318-50-6，MA-PEG4-VA-PBD ， ADC试剂 |
203 |
kx |
2024-12-19 |
| 83192 |
CAS: 2259318-55-1 - DBCO-(PEG2-VC-PAB-MMAE)2 |
98 |
WYQ |
2024-12-19 |
| 83193 |
CAS: 2768446-73-5，DBCO-Val-Cit-PAB-MMAE |
132 |
WYQ |
2024-12-19 |
| 83194 |
MC-vc-PAB-C6-a-amanitin， ADC试剂 |
124 |
kx |
2024-12-19 |
| 83195 |
cas:663598-98-9，2,5-dioxopyrrolidin-1-yl 4-methyl-4-((5-nitropyridin-2-yl)disulfanyl)pentanoate，ADC定制 |
130 |
wyh |
2024-12-19 |
| 83196 |
cas:2873452-49-2 MC-EVCit-PAB-MMAE |
131 |
zyl |
2024-12-19 |
| 83197 |
2,5-dioxopyrrolidin-1-yl 3-methyl-3-(pyridin-2-yldisulfanyl)butanoate，ADC定制 |
158 |
wyh |
2024-12-19 |
| 83198 |
cas:159857-70-2 MC-Val-Cit-Doxorubicin |
158 |
zyl |
2024-12-19 |
| 83199 |
Gly3-vc-PAB-MMAE， ADC试剂 |
162 |
kx |
2024-12-19 |
| 83200 |
CAS: 1869126-64-6， Azido-PEG4-Val-Cit-PAB-MMAE |
142 |
WYQ |
2024-12-19 |
| 83201 |
cas:2353409-54-6 ， Mal-amido-PEG8-Val-Gly，ADC定制 |
159 |
wyh |
2024-12-19 |
| 83202 |
Azido-PEG4-Val-Ala-PAB-PNP |
158 |
zyl |
2024-12-19 |
| 83203 |
NOTA-(NGR)2 NOTA偶联NGR二聚体 |
121 |
h |
2024-12-19 |
| 83204 |
1-(2,5-dioxopyrrolidin-1-yloxy)-4-((5-nitropyridin-2-yl)disulfanyl)-1-oxobutane-2-sulfonic acid，ADC定制 |
119 |
wyh |
2024-12-19 |
| 83205 |
CAS: 1343476-44-7，Val-Ala-PAB-OH |
116 |
WYQ |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询